Editor's Choice
AIA snags Acenda head of products
AIA Australia has welcomed a new head of partnerships, who joined from Acenda after leaving the firm in March.
Praemium chief exits amid leadership renewal
Praemium is reshuffling its top leadership to refresh its strategy, keeping the same goals but with "faster pace, better execution and increased focus on customers".
ASIC lifts stop orders against Remara
ASIC has lifted three interim stop orders against Remara Investment Management's private credit products, after it amended its target market determination (TMD).
Brookfield-owned Oaktree raises US$2bn for private credit fund
Brookfield-owned Oaktree has achieved its target fund raise of US$2 billion for its Asset-Backed Financial Fund.
Further Reading
Products
Expert Feed
When geopolitics becomes a portfolio risk
Geopolitics is back - again - and Australian investors can no longer treat it as distant background noise.
Does association membership still matter?
With all the changes the advice sector has experienced in recent years, such as regulatory reform and increased education and professional standards ...
Digital assets and where they stand in 2026
So far in 2026 digital assets have captured the headlines largely for the wrong reasons, but that doesn't tell the full story.
Rethinking default design in a changing market environment
The evolution underway in the US DC system highlights the value of periodically reassessing default design assumptions.
Featured Profile
Cliff Man
CHIEF EXECUTIVE OFFICER
ETF SHARES MANAGEMENT LTD
ETF SHARES MANAGEMENT LTD
ETF Shares chief executive Cliff Man spent his career automating, building and challenging established systems. Now, he is betting that Australia's ETF market has room for something different. Vinny Vucago writes.
The Financial Standard podcast Tune in each week as we discuss the latest developments in Australia's wealth management industry. |  |
What is the denominator for the figures quoted? ie of the 370 claims relating to suicide, 516 relating to TPD as a result of mental illness, and 514 IP claims related to mental illness, what is the overall number of claims? What is the overall portfolio size? The figures without a baseline is meaningless to compare and for any company to benchmark?